FI951298A7 - 2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus - Google Patents

2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus Download PDF

Info

Publication number
FI951298A7
FI951298A7 FI951298A FI951298A FI951298A7 FI 951298 A7 FI951298 A7 FI 951298A7 FI 951298 A FI951298 A FI 951298A FI 951298 A FI951298 A FI 951298A FI 951298 A7 FI951298 A7 FI 951298A7
Authority
FI
Finland
Prior art keywords
kynureninase
kynurenine
phenyl
amino
acid derivatives
Prior art date
Application number
FI951298A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI951298L (fi
FI951298A0 (fi
Inventor
Mario Varasi
Antonio Giordani
Carmela Speciale
Massino Cini
Alberto Bianchetti
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of FI951298L publication Critical patent/FI951298L/fi
Publication of FI951298A7 publication Critical patent/FI951298A7/fi
Publication of FI951298A0 publication Critical patent/FI951298A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI951298A 1993-07-23 1994-07-12 2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus FI951298A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93MI001649A IT1265101B1 (it) 1993-07-23 1993-07-23 Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
PCT/EP1994/002280 WO1995003271A1 (en) 1993-07-23 1994-07-12 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity

Publications (3)

Publication Number Publication Date
FI951298L FI951298L (fi) 1995-03-20
FI951298A7 true FI951298A7 (fi) 1995-03-20
FI951298A0 FI951298A0 (fi) 1995-03-20

Family

ID=11366678

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951298A FI951298A0 (fi) 1993-07-23 1994-07-12 2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus

Country Status (21)

Country Link
US (1) US20010008947A1 (cg-RX-API-DMAC10.html)
EP (1) EP0662948B1 (cg-RX-API-DMAC10.html)
JP (1) JPH08501805A (cg-RX-API-DMAC10.html)
KR (1) KR950703517A (cg-RX-API-DMAC10.html)
CN (1) CN1112786A (cg-RX-API-DMAC10.html)
AT (1) ATE171935T1 (cg-RX-API-DMAC10.html)
AU (1) AU678273B2 (cg-RX-API-DMAC10.html)
CA (1) CA2144521A1 (cg-RX-API-DMAC10.html)
DE (1) DE69413789T2 (cg-RX-API-DMAC10.html)
DK (1) DK0662948T3 (cg-RX-API-DMAC10.html)
ES (1) ES2123801T3 (cg-RX-API-DMAC10.html)
FI (1) FI951298A0 (cg-RX-API-DMAC10.html)
HU (1) HUT70478A (cg-RX-API-DMAC10.html)
IL (1) IL110365A (cg-RX-API-DMAC10.html)
IT (1) IT1265101B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ268896A (cg-RX-API-DMAC10.html)
PL (1) PL179857B1 (cg-RX-API-DMAC10.html)
RU (1) RU2139850C1 (cg-RX-API-DMAC10.html)
TW (1) TW268937B (cg-RX-API-DMAC10.html)
WO (1) WO1995003271A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA945425B (cg-RX-API-DMAC10.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519055A (en) * 1993-08-06 1996-05-21 University Of Maryland At Baltimore Substituted kynurenines and process for their preparation
US5786508A (en) * 1994-07-15 1998-07-28 Pharmacia & Upjohn S.P.A. Substituted kynurenines and process for their preparation
GB9521486D0 (en) * 1995-10-20 1995-12-20 Pharmacia Spa Fluoro-substituted benzoylpropionic acid derivatives
GB9615441D0 (en) * 1996-07-23 1996-09-04 Pharmacia Spa Benzoylpropionic acid ester derivatives
EP0923569B1 (en) * 1996-08-16 2004-11-17 Warner-Lambert Company Llc Butyric acid matrix metalloproteinase inhibitors
GB9618349D0 (en) * 1996-09-03 1996-10-16 Pharmacia Spa N-substituted 2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
GB9716103D0 (en) * 1997-07-30 1997-10-01 Pharmacia & Upjohn Spa Condensed heterocyclic compounds
GB9725055D0 (en) * 1997-11-26 1998-01-28 Pharmacia & Upjohn Spa 1,3,4-thiadiazoles compounds
GB9725141D0 (en) * 1997-11-27 1998-01-28 Pharmacia & Upjohn Spa Benzenesulfonamide compounds
DE69932414T2 (de) * 1998-02-23 2007-02-22 South Alabama Medical Science Foundation, Mobile Indol-3-propionsäure, salze und ester davon als arzneimittel #
US6783965B1 (en) * 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
PT1129066E (pt) * 1998-11-11 2005-05-31 Taito Co Producao de 2-amino-2-[2-(4-c2-20-alquil-fenil)etil]propano-1,3-diois
CN1144779C (zh) * 1999-03-11 2004-04-07 杭州中美华东制药有限公司 制备2-[2-(4-烷基苯基)-乙基]-2-氨基-丙二醇的方法以及其中制得的中间产物
EP1461323B1 (en) * 2001-06-12 2013-10-09 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
FR2827045B1 (fr) 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
FR2827859B1 (fr) 2001-07-30 2005-09-23 Lipha Derives 4-(arylthio) - ou 4-(heteroarylthio) -butyrique dans la preparation de medicaments destines au traitement du diabete
CN1330774C (zh) * 2002-03-01 2007-08-08 国家人类基因组南方研究中心 犬尿氨酸水解酶多态性及其用途
ITMI20041626A1 (it) * 2004-08-06 2004-11-06 Roberto Pellicciari Inibitori della chinurenina-ammino-trasferasi
CN1309702C (zh) * 2005-10-28 2007-04-11 中国科学院上海有机化学研究所 犬尿氨酸酶的特异性抑制剂l-邻甲氧基苯甲酰基丙氨酸的合成方法
ES2536552T3 (es) 2008-03-19 2015-05-26 Novartis Ag Proceso para la preparación de 2-amino-2-[2-(4-alquil-C3-C21-fenil)etil]propano-1,3-dioles
AU2015321365B2 (en) * 2014-09-26 2021-05-20 The University Of British Columbia A combination of kynurenine and antigen presenting cells (APC) as therapeutics and methods for their use in immune modulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI96313C (fi) * 1990-11-28 1996-06-10 Daiichi Seiyaku Co Menetelmä terapeuttisesti käyttökelpoisten ja optisesti aktiivisten 10-(3-amino-4,4-dialkyyli-1-pyrrolidinyyli)-9-fluori-2,3-dihydro-3(S)-metyyli-7-okso-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihappojen valmistamiseksi
EP0501378B1 (en) * 1991-02-28 1995-01-11 Merrell Dow Pharmaceuticals Inc. NMDA Antagonists
US5495044A (en) * 1991-04-18 1996-02-27 University Of Georgia Research Foundation, Inc. Inhibitors of kynureninase
US5516936A (en) * 1991-04-18 1996-05-14 University Of Georgia Research Foundation, Inc. Inhibitors of kynureninase
GB9325360D0 (en) * 1993-12-10 1994-02-16 Univ Bristol Organic compounds

Also Published As

Publication number Publication date
IL110365A (en) 1998-06-15
ES2123801T3 (es) 1999-01-16
AU678273B2 (en) 1997-05-22
US20010008947A1 (en) 2001-07-19
ITMI931649A0 (it) 1993-07-23
TW268937B (cg-RX-API-DMAC10.html) 1996-01-21
CA2144521A1 (en) 1995-02-02
FI951298L (fi) 1995-03-20
DK0662948T3 (da) 1999-06-21
PL308142A1 (en) 1995-07-24
DE69413789T2 (de) 1999-05-06
PL179857B1 (pl) 2000-11-30
WO1995003271A1 (en) 1995-02-02
JPH08501805A (ja) 1996-02-27
KR950703517A (ko) 1995-09-20
IL110365A0 (en) 1994-10-21
DE69413789D1 (de) 1998-11-12
RU95111308A (ru) 1996-12-27
NZ268896A (en) 1997-01-29
HUT70478A (en) 1995-10-30
ATE171935T1 (de) 1998-10-15
CN1112786A (zh) 1995-11-29
EP0662948A1 (en) 1995-07-19
ZA945425B (en) 1995-03-01
HU9501146D0 (en) 1995-06-28
RU2139850C1 (ru) 1999-10-20
EP0662948B1 (en) 1998-10-07
ITMI931649A1 (it) 1995-01-23
FI951298A0 (fi) 1995-03-20
IT1265101B1 (it) 1996-10-30
AU7228594A (en) 1995-02-20

Similar Documents

Publication Publication Date Title
FI951298A7 (fi) 2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus
FI954404L (fi) Fenoksifenyylietikkahappojohdannaiset
FI941213L (fi) Naftaleenijohdannaisia
FI960130A7 (fi) Hepariinijohdannaiset, joilla on etäpesäkkeitä vastustava vaikutus
FI972460L (fi) Aniliinijohdannaiset joilla on typpimonoksidisyntaasiesto aktiivisuus
FI942923A7 (fi) Propeenihappojohdannaiset
FI962022L (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
FI942976A7 (fi) 5-amino-8-metyyli-7-pyrrolidinyylikinoliini-3-karboksyylihappojohdannaiset
FI962021L (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
FI901957A7 (fi) Dipeptidijohdannaisia, joilla on entsyymiä estävä vaikutus
FI963891L (fi) Elastaasia inhiboivaa aktiivisuutta sisältävät alfa-l-antikymotrypsiinianalogit
NO982977L (no) Tiolderivater med metallopeptidasehemmende aktivitet
FI961202L (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
NO306299B1 (no) Oksatiolaner og farmasöytiske preparater med antiviral virkning som inneholder de samme
DE59402621D1 (de) Fluor-trifluormethylbenzoesäure-Derivate
FI941149L (fi) 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
FI963222L (fi) 6-substituoitu 4-amino-mykofenolihappo ja sen johdannaiset, joilla on immunosuppressiivista aktiivisuutta
FI941064A7 (fi) Asyylioksiheksaanihappojohdannaiset
ATA231194A (de) Häcksler
FI963316A7 (fi) Hiilihapon diesterit, joilla on viruksia torjuvaa ja tulehdusta torjuv aa aktiivisuutta
BR9408162A (pt) Derivados de ácido 2,3,5,6-tetrafluorbenzóico
FI960026L (fi) Värejä, joissa on tetra-aminopyrimidiiniä ja suoravärjäysaineita
TR27956A (tr) Hidroksietil-azolil türevleri.
NO951100D0 (no) 2-amino-4-fenyl-4-oksosmörsyrederivater med kynurinase- og/eller kynurenin-3-hydroksylase-inhiberende aktivitet
KR950017357U (ko) 손목형 요절집

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN S.P.A.